[GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease]
Gastroenterol Hepatol
.
2005 Mar;28(3):126-34.
doi: 10.1157/13072012.
[Article in Spanish]
Authors
E Domènech
1
,
M Esteve
,
F Gomollón
,
J Hinojosa
,
J Panés
,
A Obrador
,
M A Gassull
;
Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Affiliation
1
Servicio de Aparato Digestivo, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
PMID:
15771858
DOI:
10.1157/13072012
No abstract available
Publication types
Practice Guideline
Review
MeSH terms
Antibodies, Monoclonal / therapeutic use*
Humans
Inflammatory Bowel Diseases / drug therapy*
Infliximab
Substances
Antibodies, Monoclonal
Infliximab